This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.
We are thrilled to offer the first CRI Virtual Immunotherapy Patient Summit. Register for free today.
Join Jane and Dick Landesman for a community-building fundraiser to benefit the Cancer Research Institute.
CRI.ContactUs
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.